Pulmonary surfactant protein D

Pulmonary surfactant protein D (SP-D) is a protein primarily involved in the innate immune defense of the lungs. It is a member of the collectin family of proteins, which are characterized by their collagen-like sequences and carbohydrate recognition domains. SP-D is synthesized and secreted by type II alveolar cells and Clara cells in the lungs. Its main function is to enhance the body's defense against inhaled microorganisms and particulate matter by binding to the surface of various pathogens and facilitating their clearance from the respiratory tract.

Structure

Pulmonary surfactant protein D is a large, multimeric protein composed of trimeric subunits. Each monomer consists of a short N-terminal region, a collagen-like domain, a neck region, and a carbohydrate recognition domain (CRD) at the C-terminus. The trimeric subunits assemble into larger oligomeric structures, which are crucial for the protein's function in recognizing and binding to pathogens.

Function

The primary role of SP-D is in the innate immune response within the lungs. By binding to surface glycoproteins and lipids on a wide range of microorganisms, including bacteria, viruses, and fungi, SP-D facilitates the opsonization and clearance of these potential pathogens. It also plays a role in modulating the inflammatory response, helping to maintain lung homeostasis and prevent tissue damage during infection.

SP-D interacts with immune cells, such as macrophages, to enhance phagocytosis and promote the clearance of pathogens and apoptotic cells. Additionally, it has been shown to have an anti-inflammatory effect by inhibiting the secretion of pro-inflammatory cytokines and by binding to allergens, thereby reducing allergic responses.

Clinical Significance

Alterations in the levels or function of SP-D have been associated with various lung diseases. Elevated levels of SP-D can be found in the serum of patients with pulmonary conditions such as Chronic Obstructive Pulmonary Disease (COPD), Interstitial Lung Disease, and Pulmonary Fibrosis. These elevated levels are thought to reflect damage to the alveolar epithelium and may serve as a biomarker for lung injury.

Conversely, deficiencies in SP-D have been linked to increased susceptibility to respiratory infections and the development of certain lung diseases. Genetic variations in the gene encoding SP-D have been associated with an increased risk of chronic lung diseases, highlighting the importance of SP-D in respiratory health.

Research Directions

Research into SP-D continues to explore its potential therapeutic applications, including its use as a biomarker for lung diseases and its therapeutic potential in treating respiratory infections and modulating the immune response in chronic lung diseases. Studies are also investigating the role of SP-D in other diseases beyond the lungs, given its involvement in the innate immune response.

See Also

• Pulmonary surfactant
• Innate immune system
• Alveolar cell
• Respiratory tract infections

Resources

Latest articles - Pulmonary surfactant protein D

• Most recent articles
• Ongoing trials

Source: Data courtesy of the U.S. National Library of Medicine. Since the data might have changed, please query MeSH on Pulmonary surfactant protein D for any updates.

‎